At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MBOT Microbot Medical Inc
Trading 06-11 12:25:06 EDT
1.79
+0.02
+1.22%
High1.81Low1.76Vol285.14K
Open1.80D1 Closing1.77Amplitude2.60%
Mkt Cap120.32MTradable Cap120.32MTotal Shares67.16M
T/O509.04KT/O Rate0.42%Tradable Shares67.16M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System
GlobeNewswire  ·  06-09 20:30
Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System
Microbot Medical Initiated at Buy by LUCID CAPITAL MARKETS
Dow Jones  ·  06-04
Microbot Medical Initiated at Buy by LUCID CAPITAL MARKETS
Microbot Medical - Secures First North Carolina Customer for Liberty Endovascular Robotic System
THOMSON REUTERS  ·  06-02
Microbot Medical - Secures First North Carolina Customer for Liberty Endovascular Robotic System
We're Hopeful That Microbot Medical (NASDAQ:MBOT) Will Use Its Cash Wisely
Simply Wall St.  ·  05-30
We're Hopeful That Microbot Medical (NASDAQ:MBOT) Will Use Its Cash Wisely
Microbot Medical announces Israel granted marketing clearance for Liberty
TIPRANKS  ·  05-26
Microbot Medical announces Israel granted marketing clearance for Liberty
Microbot Medical wins Israeli clearance to market LIBERTY endovascular robotic system
Reuters  ·  05-26
Microbot Medical wins Israeli clearance to market LIBERTY endovascular robotic system
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the Liberty® Endovascular Robotic System
THOMSON REUTERS  ·  05-26
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the Liberty® Endovascular Robotic System
Microbot Medical pushes back on third-party article, plans call to correct misstatements
Reuters  ·  05-15
Microbot Medical pushes back on third-party article, plans call to correct misstatements
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu
GlobeNewswire  ·  05-15
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu
Microbot Medical: Recorded Revenue During Its Qtr Ended March 31, Benefiting From Limited Market Release of Liberty System
THOMSON REUTERS  ·  05-14
Microbot Medical: Recorded Revenue During Its Qtr Ended March 31, Benefiting From Limited Market Release of Liberty System
Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026
GlobeNewswire  ·  05-14
Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026
Microbot Medical Inc reports results for the quarter ended December 31 - Earnings Summary
Reuters  ·  05-14
Microbot Medical Inc reports results for the quarter ended December 31 - Earnings Summary
Microbot Medical Inc expected to post a loss of 8 cents a share - Earnings Preview
Reuters  ·  05-09
Microbot Medical Inc expected to post a loss of 8 cents a share - Earnings Preview
Microbot Medical®’S Liberty® Endovascular Robotic System Is NOW Adopted by Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
THOMSON REUTERS  ·  05-05
Microbot Medical®’S Liberty® Endovascular Robotic System Is NOW Adopted by Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites
GlobeNewswire  ·  05-05
Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites
Microbot Medical appoints Alon Tamir as VP of Sales for EMEA
Reuters  ·  04-30
Microbot Medical appoints Alon Tamir as VP of Sales for EMEA
Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)
GlobeNewswire  ·  04-30
Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)
Microbot Medical says updated radiation guidelines boost LIBERTY system positioning
Reuters  ·  04-22
Microbot Medical says updated radiation guidelines boost LIBERTY system positioning
Microbot Medical to present at Needham Virtual Healthcare Conference
Reuters  ·  04-15
Microbot Medical to present at Needham Virtual Healthcare Conference
Microbot Medical Price Target Maintained With a $12.00/Share by HC Wainwright & Co.
Dow Jones  ·  04-14
Microbot Medical Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Introduction

Company Name.
Microbot Medical Inc
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, a disposable robotic system for use in endovascular interventional procedures, such as cardiovascular, peripheral, and neurovascular; NovaCross, an intraluminal revascularization device; ViRob, an autonomous crawling micro-robot that cam crawl in various natural spaces within the human body, including blood vessels, the digestive tract and the respiratory system, as well as artificial spaces such as shunts, catheters, ports, etc.; TipCAT, a disposable self-propelled locomotive device for tubular anatomies; and One & Done platform. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Issue price:
--